• Your portfolio is 100% ETFs — TIKR adds zero value to that workflow.
• You want technical charts, RSI, MACD, or moving averages — wrong tool entirely.
• You only invest in domestic blue-chips already covered well by free tools.
• You’re not yet comfortable reading income statements or EV/EBITDA multiples.
• You log in less than once a week — you’ll pay for idle access you’ll rarely use.

Income statement, balance sheet, and cash flow in a single scrollable interface. Up to 20 years of annual and quarterly data depending on the company. You can toggle between consolidated and standalone reporting, which matters for holding companies and conglomerates. Multi-year charting on any line item — revenue CAGR, margin expansion, debt paydown — is built in, not a workaround.

P/E, EV/EBITDA, P/FCF, P/S, and a full suite of trailing and forward multiples. More useful than a snapshot: TIKR plots valuation history on a chart so you can see where the current multiple sits relative to its own 10-year range. Peer comparison lets you stack the target against a custom set of competitors on any metric.

Aggregated Wall Street consensus for revenue, EPS, EBITDA, and margin over 5 forward years. Crucially, you can track how estimates have moved over time — whether analysts are consistently upgrading or downgrading a name, which is often more useful than the estimate itself. Not individual analyst breakdowns; consensus aggregates only.

Filter across 100,000+ stocks using valuation multiples, profitability metrics, growth rates, analyst forecast changes, balance sheet ratios, and capital structure. Geography, sector, and market cap filters narrow the universe. The screener covers non-US markets properly — you can run a screen for profitable small-caps in the Eurozone with positive estimate revisions, which most US-built screeners cannot do cleanly.

A searchable library of earnings call transcripts and investor day filings. This is the qualitative layer: management language, forward guidance, Q&A tone, and capital allocation signals. Competitors often lack this for non-US companies — TIKR’s transcript coverage extends internationally, though depth varies by market and company size.

Track the portfolio moves of 10,000+ institutional investors, hedge funds, and corporate insiders globally. The coverage goes beyond standard US 13F filings — a meaningful advantage for investors researching non-US companies where US-only databases are blind. You can see what a specific fund owns, track entry and exit timing, and flag insider buying or selling activity.

TIKR’s built-in valuation tool lets you construct forward-looking Bull, Base, and Bear scenarios for DCF or relative valuation models without needing a spreadsheet. Pre-populated with TIKR’s fundamental data, you adjust growth rates, margins, and discount rates — and the model updates in real time. It is not a replacement for a serious Excel model, but it significantly lowers the barrier to sanity-checking a valuation quickly. For investors who have always wanted to build DCF models but found the blank-spreadsheet start overwhelming, this is the most accessible entry point available at this price.

• Basic US stock fundamentals
• Limited financial history (shorter lookback)
• Capped screener functionality
• No global coverage (paid-only)
• No transcripts, no institutional ownership

The free tier is a trial, not a working research setup. It is enough to test the interface and decide whether the workflow suits you — not enough to do serious cross-market research.

This is the most direct comparison and the one worth spending time on. Koyfin is a stronger macro platform: custom dashboards, economic data, FX, portfolio monitoring, and a cleaner interface make it better for investors who want a broad market overview. TIKR goes deeper on individual companies: longer financial statement history, a larger transcript library, and more granular ownership data that goes beyond US 13F filings.

The practical split: if you spend more time looking at macro trends and monitoring a watchlist, Koyfin fits better. If you spend time digging into single-company financials and building valuation models, TIKR wins. Many serious fundamental investors use both and treat them as complementary — Koyfin for the top-down filter, TIKR for the bottom-up deep dive. See the full TIKR vs Koyfin comparison for a side-by-side breakdown.

Simply Wall St automates the analysis layer: it turns raw fundamentals into visual summaries, health scores, and narrative assessments. That makes it more accessible for investors who are not comfortable reading raw financial statements. The trade-off is that the automation hides the underlying numbers — you are trusting the tool’s interpretation rather than forming your own.

TIKR gives you the raw data and makes you do the thinking. For an investor who wants to understand a business thoroughly — not just consume a rating — TIKR is the more powerful tool. Simply Wall St is the better starting point for someone earlier in the learning curve who needs the guidance layer before working with raw statements.

Stock Analysis is free and genuinely excellent for US-listed companies: clean financial statements, valuation multiples, earnings history, and basic institutional ownership. For US-only investors who do not need transcripts or the advanced screener, Stock Analysis may be the honest answer — and it costs nothing.

TIKR wins when you need global coverage, longer history, transcript access, or the full screener across international markets. If your research is limited to US large- and mid-caps with good free tool coverage, TIKR’s paid subscription is hard to justify. If you research European or Asian companies regularly, TIKR has no comparable free alternative. See the full TIKR vs Stock Analysis comparison, or Stock Analysis vs Koyfin if you are deciding between the free option and the visual terminal.

• No technical analysis whatsoever — charts, indicators, and price alerts are absent by design.
• Real-time data is restricted to higher-tier plans; lower tiers carry a data lag.
• Pricing has increased significantly since the free beta days — the value calculation has shifted.
• No portfolio tracking, execution, or tax reporting — it is a research tool only.
• The free tier is a trial, not a usable research environment for serious work.
• Data density and interface complexity require a learning investment. Not beginner-friendly.
• Transcript and ownership depth varies — smaller international companies may have gaps.

• Your portfolio is built entirely around ETFs and index funds.
• You need technical charts, indicators, or price alert tools.
• Your research is limited to large US stocks already well-covered by free tools.
• You are still building your financial literacy — the data density will work against you.
• You want a portfolio tracker or tax reporting tool alongside your research platform.
• You are not willing to spend real time learning the interface and workflow.